Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant negative strand RNA virus expression systems

Recombinant negative strand RNA virus expression systems

US Patent 5840520 · Granted Nov 24, 1998

Estimated economic value: $5,917,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV2025
Mosaic influenza virus hemagglutinin polypeptides and uses thereof2025
Influenza virus hemagglutinin proteins and uses thereof2025
Newcastle disease viruses and uses thereof2024
Anti-influenza B virus neuraminidase antibodies and uses thereof2024
Influenza virus hemagglutinin proteins and uses thereof2024
Influenza virus hemagglutinin proteins and uses thereof2022
Anti-influenza B virus neuraminidase antibodies and uses thereof2022
Influenza virus vaccination regimens2020
Influenza virus vaccines and uses thereof2020
Genetically engineered swine influenza virus and uses thereof2020
Antibodies against influenza virus hemagglutinin and uses thereof2020